Clinical Trial Update: Obeticholic Acid in Bariatric and Gallstone Disease [Phase 2]

View source ↗

Summary

This clinical trial update notes that a Phase 2 study of obeticholic acid for obesity-related bariatric and gallstone disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallstone Disease
• Obesity

Drugs mentioned

• Ocaliva (obeticholic acid)

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: Obesity, Gallstones | Phase 2 | Status: COMPLETED